03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Dynastat° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Food & Drug Corporation |
Distributor | Food & Drug Corporation |
Laboratory | Pfizer |
Responsible Party | Pfizer Ltd |
Origin | UK |
Manufacturer | Pharmacia & Upjohn Company |
Origin | U.S.A. |
ATC | M01AH04 |
Dynastat° :
Dynastat° :
Dynastat° :
Dynastat° :
Dynastat° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Dynastat° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abnormal sternal serous wound drainage | Uncommon |
Agitation | Common |
ALT increased | Uncommon |
Alveolar osteitis | Common |
Anaemia postoperative | Common |
Anaphylactoid reactions | Rare |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anorexia | Uncommon |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
AST increased | Uncommon |
Asthenia | Uncommon |
Back pain | Common |
Blood creatine phosphokinase increased | Uncommon |
Blood creatinine increased | Common |
Blood urea nitrogen (BUN) increased | Uncommon |
Bradycardia | Uncommon |
Cerebrovascular disorders | Uncommon |
Circulatory collapse | Not known |
Congestive heart failure | Not known |
Constipation | Common |
Dermatitis exfoliative | Not known |
Dizziness | Common |
Dry mouth (Xerostomia) | Uncommon |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Not known |
Ecchymosis | Uncommon |
Erythema multiforme | Not known |
Flatulence | Common |
Gastroduodenal ulcer | Uncommon |
Gastrointestinal sounds abnormal | Uncommon |
Gastrooesophageal reflux disease | Uncommon |
Hyperglycaemia | Uncommon |
Hyperhidrosis | Common |
Hypersensitivity reactions | Not known |
Hypertension | Common |
Hypertension worsened | Uncommon |
Hypoesthesia | Common |
Hypokalaemia | Common |
Hypotension | Common |
Injection site pain | Uncommon |
Injection site reaction | Uncommon |
Insomnia | Common |
LDH elevated | Uncommon |
Myocardial infarction | Uncommon |
Nausea | Very Common |
Oedema mouth | Rare |
Oedema peripheral | Common |
Oesophagitis | Rare |
Oliguria | Common |
Orthostatic hypotension | Uncommon |
Otalgia (Earache) (Ear pain) | Uncommon |
Pancreatitis | Rare |
Pharyngitis | Common |
Post procedural complication | Uncommon |
Pruritus | Common |
Pulmonary embolism | Uncommon |
Renal failure | Not known |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Rare |
Respiratory insufficiency | Common |
Skin rash | Uncommon |
Stevens-Johnson syndrome | Not known |
Tachycardia | Not known |
Thrombocytopenia (Thrombopenia) | Uncommon |
Urticaria | Uncommon |
Vomiting | Common |
Wound infection | Uncommon |
NB : Products With Same Indication |
Different Units By MoH Code
Dynastat° MoH 9057 :
Form | Powder and solvent for solution for injection |
Packaging | Bottle (Glass) + Ampoules (Glass) |
Package Size | Box of 5+5 |
Strength | 40mg |
Storage Condition | <25°C None |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 154116/1 |
Submission date | 11/03/2016 |
Registration Year | 2017 |
Withdrawn Date | 03/12/2020 |
Price Comparison
You have to register to view this info
Drop File